Raymond James Maintains Outperform on NGM Biopharmaceuticals, Raises Price Target to $27
Raymond James analyst Steven Seedhouse maintains NGM Biopharmaceuticals (NASDAQ:NGM) with a Outperform and raises the price target from $22 to $27.
NGM Biopharmaceuticals Q2 EPS $(0.48) Down From $(0.38) YoY, Sales $16.77M Down From $19.75M YoY
NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.48) per share. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported $16.77 million
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
NGM Bio Announces Initiation Of Phase 1/2 Clinical Study Of NGM707 For Treatment Of Advanced Solid Tumors
--NGM707, a ILT2/ILT4 dual antagonistic antibody, is engineered to reverse myeloid suppression with the goal of improving patient immune responses to tumors--
--Study to evaluate potential of NGM707 in patients
NGM Biopharma, Merck Amend Development Pact To Focus On Retinal, Cardiovascular & Metabolic Targets
NGM Biopharmaceuticals Inc (NASDAQ:NGM) has amended and restated an agreement with Merck & Co Inc (NYSE:MRK) to extend their ongoing collaboration through March…
52 Biggest Movers From Yesterday
Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive immuno-oncology RNA therapy for the treatment of multiple cancers.
Analyst Reactions on NGM Biopharmaceuticals Disappointing Aldafermin Data in NASH Study
Today, NGM Biopharmaceuticals Inc (NASDAQ: NGM)
Mid-Afternoon Market Update: Dow Jumps 250 Points; Scopus BioPharma Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.75% to 34,462.98 while the NASDAQ rose 1.64% to 13,691.64. The S&P also rose, gaining 1.25% to 4,207.76.
Why Scopus, NGM Biopharma and Taiwan Liposome Are Moving Today
Scopus BioPharma Inc. (NASDAQ: SCPS), NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) and Taiwan Liposome Company, Ltd.